Tech Company Financing Transactions
Quell Therapeutics Funding Round
Quell Therapeutics closed a $156 million Series B funding round on 11/30/2021. Investors included Fidelity Management & Research Company, JEITO and Ridgeback Capital.
Transaction Overview
Fidelity Management & Research Company (Lead Investor)
JEITO (Lead Investor) (Rachel Mears)
Ridgeback Capital (Lead Investor) (Jeffrey Long-McGie)
SV Health Investors (Lead Investor) (Houman Ashrafian)
Monashee Investment Management
Syncona (Martin Murphy)
Company Information
London, W12 OBZ
UK
Management Team
Browse more venture capital transactions:
Prev: 11/30/2021: Forest venture capital transaction
Next: 11/30/2021: Motorway venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs